Blue Earth Diagnostics to develop and commercialise molecular imaging agents addressing areas of high un-met medical need. The company is named after Blue Earth County, Minnesota where Sir Henry Wellcome (1853-1936), the founder of the Wellcome Trust, spent his childhood.
2nd
PepgenPepGen is empowering nucleic acid therapeutics to go the distance.
DJS Antibodies is developing novel therapeutics to treat chronic inflammatory diseases. DJS does this through the discovery and development of novel therapeutic monoclonal antibodies against GPCRs.
Total amount:5
The top three largest startup exits in Oxford have raised total funding of more than USD 0. Among the top three funded exits, the most popular industry, based on total funding, is Energy & Environment.
Oxford Nanopore Technologies aims to disrupt the paradigm of biological analysis. Our technology and commercial model has already opened up DNA analysis to researchers who previously had no direct access to sequencing technologies, freeing them up to perform analyses in their own labs or in the field, and in real time. Oxford Nanopore has developed the world's first and only nanopore DNA sequencer, the MinION. The MinION is a portable, real-time, long-read, low-cost device that has been designed to bring easy biological analyses to anyone, whether in scientific research, education or a range of real-world applications such as disease/pathogen surveillance, environmental monitoring, food-chain surveillance, self-quantification or even microgravity biology.
Blue Earth Diagnostics to develop and commercialise molecular imaging agents addressing areas of high un-met medical need. The company is named after Blue Earth County, Minnesota where Sir Henry Wellcome (1853-1936), the founder of the Wellcome Trust, spent his childhood.
3rd
MiroBioMiroBio's platform is based on ground-breaking research by their scientific founders at the University of Oxford delineating how immune cells communicate and how they are activated.
Total amount:5
The top three hiring startup exits in Oxford have an average employee size that is smaller than to the global average. Among these, the Healthtech industry features the startup exit with the largest workforce.
Oxford Nanopore Technologies aims to disrupt the paradigm of biological analysis. Our technology and commercial model has already opened up DNA analysis to researchers who previously had no direct access to sequencing technologies, freeing them up to perform analyses in their own labs or in the field, and in real time. Oxford Nanopore has developed the world's first and only nanopore DNA sequencer, the MinION. The MinION is a portable, real-time, long-read, low-cost device that has been designed to bring easy biological analyses to anyone, whether in scientific research, education or a range of real-world applications such as disease/pathogen surveillance, environmental monitoring, food-chain surveillance, self-quantification or even microgravity biology.
2nd
PepgenPepGen is empowering nucleic acid therapeutics to go the distance.
DJS Antibodies is developing novel therapeutics to treat chronic inflammatory diseases. DJS does this through the discovery and development of novel therapeutic monoclonal antibodies against GPCRs.
4th
MiroBioMiroBio's platform is based on ground-breaking research by their scientific founders at the University of Oxford delineating how immune cells communicate and how they are activated.
Total amount:5
The top three famous startup exits in Oxford have average website traffic that is higher than to the global average. Among the top three exits, the most famous industry, based on total website traffic, is Healthtech.
Oxford Nanopore Technologies aims to disrupt the paradigm of biological analysis. Our technology and commercial model has already opened up DNA analysis to researchers who previously had no direct access to sequencing technologies, freeing them up to perform analyses in their own labs or in the field, and in real time. Oxford Nanopore has developed the world's first and only nanopore DNA sequencer, the MinION. The MinION is a portable, real-time, long-read, low-cost device that has been designed to bring easy biological analyses to anyone, whether in scientific research, education or a range of real-world applications such as disease/pathogen surveillance, environmental monitoring, food-chain surveillance, self-quantification or even microgravity biology.
2nd
PepgenPepGen is empowering nucleic acid therapeutics to go the distance.
Blue Earth Diagnostics to develop and commercialise molecular imaging agents addressing areas of high un-met medical need. The company is named after Blue Earth County, Minnesota where Sir Henry Wellcome (1853-1936), the founder of the Wellcome Trust, spent his childhood.
Total amount:5
National Rank
(United Kingdom)
4th
0
Regional Rank
(Western Europe)
21st
0
Global Rank
(WorldWide)
99th
3
Oxford exits in the Healthtech industry are overperforming their global industry peers. The top three Healthtech exits in Oxford have raised more than USD 508M, an amount that is higher than the global industry average.
Blue Earth Diagnostics to develop and commercialise molecular imaging agents addressing areas of high un-met medical need. The company is named after Blue Earth County, Minnesota where Sir Henry Wellcome (1853-1936), the founder of the Wellcome Trust, spent his childhood.
2nd
PepgenPepGen is empowering nucleic acid therapeutics to go the distance.
DJS Antibodies is developing novel therapeutics to treat chronic inflammatory diseases. DJS does this through the discovery and development of novel therapeutic monoclonal antibodies against GPCRs.
Total amount:5
